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Dept of Analysis
1. INTRODUCTION
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
INTRODUCTION  (1)
HPLC was introduced commercially in 1969 and since then it has undergone extensive
modifications and innovation, which lead to its emergence as the foremost analytical tool for
quantitative analysis. HPLC is a type of liquid chromatography that employs a liquid mobile
phase and a very finely divided stationary phase. In order to obtain a satisfactory flow rate liquid
must be pressurized to a few thousands of pounds per square inch.
Fig.1 HPLC System.
The rate of distribution of drugs between stationary and mobile phase is controlled by
diffusion process. If diffusion is minimized, a faster and effective separation can be achieved.
The technique of HPLC is so called because of its improved performance when compared to
classical  column  chromatography.  Advances  in  column  technology,  high-pressure  pumping
system and sensitive detectors have transformed liquid column chromatography into high speed,
efficient, accurate and highly resolved method of separation.
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The HPLC is the method of choice in the field of analytical chemistry, since this method
is specific, robust, linear, precise and accurate and the limit of detection is low and also it offers
the following advantages,
• Speed (many analysis can be accomplished in 20 min or less)
• Greater sensitivity (various detectors can be employed)
• Improved Resolution (wide variety of stationary phases)
• Reusable columns
• Ideal for the substances of low volatility
• Easy sample recovery, handling and maintenance
• Instrumentation leads itself to automation and quantization
• Precise and Reproducible
• Calculations are done by integrator itself
TYPES OF HPLC TECHNIQUES:
Based on modes of chromatography:
• Reverse phase chromatography
• Normal phase chromatography
Based on principle of separation:
• Adsorption chromatography
• Ion exchange chromatography
• Size exclusion chromatography
• Affinity chromatography
• Chiral phase chromatography
Based on elution technique:
• Isocratic separation 
• Gradient separation
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Based on the scale of operation:
• Analytical HPLC 
• Preparative HPLC
Reversed phase chromatography
In 1960s, chromatographers started modifying the polar nature of the silanol group by
chemically reacting silicon with organic silanes. 
   The object was to make silica less polar or non-polar so that polar solvents can be used to
separate water-soluble polar compounds. Since the ionic nature of the chemically modified silica
in now reversed i.e., it is non-polar or the nature of the phase is reversed, the chromatographic
separation carried out with such silica is referred to as reversed-phase chromatography.
A large  number  of  chemically  bonded  silica  based  stationary  phases  are  available
commercially.  Silica  based  stationary  phases  are  still  more  popular  in  reversed  phase
chromatography;  however  other  adsorbents  based  on  polymer  (styrene  divinyl  benzene
copolymer) are slowly gaining ground.
The less water-soluble compounds are better retained by the reversed phase surface. The
retention  time  decreases  in  the  following  order:  Aliphatic  >  induced  dipoles  (E.g.  CCl4)  >
permanent dipoles (E.g. CHCl3) > weak Lewis bases (Ethers, aldehydes, ketones) > strong Lewis
bases (amines) > weak Lewis acids (alcohols, phenols) > strong Lewis acids (carboxylic acids).
Also the retention increases as the number of carbon atoms increases.
As a general rule, the retention increases with an increase in the contact area between
sample molecule and stationary phase i.e., with an increase in the number of water molecules,
which are released during the adsorption of a compound. Branched chain compounds are eluted
more rapidly than their corresponding normal isomers.
In reversed phase system the strong attractive forces between water molecules arising
from the  3-dimensional  intermolecular  hydrogen  bonded network  present  in  the  structure of
water must be distorted or disrupted when a solute is dissolved.
Km college of pharmacy
Page 3
Dept of Analysis
Only higher polar or ionic solutes can interact with the water structure. Now polar solutes
are squeezed out of the mobile phase and are relatively insoluble in it, but with the hydrogen
carbon moieties of the stationary phase.
Chemically bonded octadecyl silane (ODS) and alkane with 18 carbon atoms is the most
popular stationary phase used in pharmaceutical industry. Since most pharmaceutical compounds
are  polar  and  water  soluble,  the  majority  of  HPLC  methods  used  for  quality  assurance,
decomposition studies, quantitative analysis of both bulk drugs and their formulations use ODS
HPLC columns. The solvent strength in reverse phase chromatography is reversed from that of
adsorption chromatography (silica gel) as stated earlier. Water interacts strongly and highly with
silanol groups, so that adsorption of sample molecules become highly restricted and they are
rapidly eluted as a result. Exactly opposite applies in reversed phase system; water cannot wet
the  non-polar  (hydrophobic)  alkyl  group  such  as  C18 of  ODS phase  and  therefore  does  not
interact with the bonded moiety. Hence water is the weakest solvent of all and gives slowest
elution rate. The elution time (retention time) in reversed phase chromatography increases with
increasing amount of water in the mobile phase.
Adsorption chromatography / normal phase chromatography
In  normal phase chromatography,  the stationary phase is  polar adsorbent.  The mobile
phase  is  generally a  mixture  of  non-aqueous  solvents.  The  silica  structure  is  saturated  with
silanol  group  at  the  end  in  normal  phase  separations.  These  OH  groups  are  statistically
distributed over the whole of  the surface.  The silanol groups represent the active sites (very
polar) in the stationary phase. 
This forms a weak bond with many molecules in the vicinity when any of the following
interactions  are  present.  Dipole-induced  dipole,  dipole-dipole,  hydrogen  bonding,  -complex
bonding.  These  situations  arise  when  the  molecule  has  one or  several  atoms with  lone  pair
electrons or a double bond. The adsorption strengths and hence ‘K’ value (elution series) increase
in  the  following  order.  Saturated  hydrocarbon  <  olefins  <  aromatic  <  organic  <  halogen
compounds < sulphides  < ethers  < esters < aldehydes  and ketones < amines  < sulphones  <
amides  <  carboxylic  acids.  The  strength  of  interactions  depends  not  only on  the  functional
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groups in the sample molecule but also on stearic factors. If a molecule has several functional
groups, then the most polar one determines the reaction properties.
Chemically modified silica, such as aminopropyl, cyanopropyl and diol phases are the
stationary phases alternative to silica gel in normal phase chromatography.
The aminopropyl and cyanopropyl phases provide opportunities for specific interactions
between  the  analyte  and  the  stationary  phase  and  thus  offer  additional  options  for  the
optimizations  of  separations.  Other  advantages  of  bonded  phases  lie  in  the  increased
homogeneity of the stationary phase surface. 
Polar modifiers such as acetic acid or triethylamine (TEA) are added to the mobile phase,
to deactivate the more polar adsorption sites on the surface of stationary phase, which in turn will
improve peak shape as well as the reproducibility of the retention times. 
Ion-exchange Chromatography
Separation is based on the charge-bearing functional groups, anion exchange for sample
negative ion, or cation exchange - for sample positive ion. Gradient elution by pH is common. 
Size Exclusion Chromatography
Also known as gel permeation or filtration, separation is based on the molecular size or
hydrodynamic volume of  the  components.  Molecules  that  are too large for  the pores  of  the
porous packing material on the column elute first, small molecules that enter the pores elute last
and the elution rates of the rest depend on their relative sizes.
Affinity/ Ion-pair Chromatography
Separation is based on a chemical interaction specific to the target species. The more
popular reversed phase mode uses a buffer and an added counter-ion of opposite charge to the
sample with separation being influenced by pH, ionic strength, temperature, concentration of and
type of organic co-solvent(s). Affinity chromatography, common for macromolecules, employs a
ligand (biologically active molecule bonded covalently to the solid matrix) which interacts with
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its homologous antigen (analyte) as a reversible complex that can be eluted by changing buffer
conditions.
Chiral Chromatography:
Separation of the enantiomers can be achieved on chiral stationary phases by formation
of diastereomers via derivatizing agents or mobile phase additives on chiral stationary phases.
When used as an impurity test method, the sensitivity is enhanced if the enantiomeric impurity
elutes before the enantiomeric drug.
Isocratic Separation:
In this technique, the same mobile phase combination is used throughout the process of
separation. The same polarity or elution strength is maintained the process.
Gradient Separation:
In this technique, a mobile phase combination of lower polarity or elution strength is used
followed by gradually increasing the polarity or elution strength.
Analytical HPLC:
In this only analysis of the samples are done. Recovery of the samples for reusing is
normally not done, since the samples used are very low.
Preparative HPLC:
Where analysis of the individual  fractions of pure compounds can be collected using
fraction collector. The collected samples are reused.
INSTRUMENTATION
PUMPS (2)
The HPLC pump is considered to be one of the most important components in a liquid
chromatography system which has to provide a continuous constant flow of the eluent through
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the HPLC injector, column and detector.  Pumps are constructed with materials such as stainless
steel, Teflon, Glass.
Standard HPLC Pump requirements are
Flow Rate Range       :    0.01 – 10 ml/min
Pressure Range          :    1 – 5,000 psi
Pressure Pulsations    :    Less than 1% for Normal and Reverse phase HPLC
                             Less than 0.2%.  for Size Exclusion Mode.
The two basic classifications are Constant Pressure Pump and Constant Flow Pump. The
first is used for column packing and the second type is most widely used in all common HPLC
applications.
Constant Pressure pump can deliver a constant flow rate if the pump operates against a
constant  column backpressure  and  if  the  viscosity  of  the  mobile  phase  remaining  constant.
Constant pressure pump may be simple gas displacement pump or pneumatic amplifier pump.
Simple gas displacement pump is a reservoir such as coil of tubing to which pressure is applied
from a  gas  cylinder.  The  disadvantage  of  this  pump  is  limited  solvent  capacity.  Pneumatic
amplifier pump is a modification of simple gas displacement pump. The gas pressure is applied
to a large piston, which is connected to a small diameter piston, which is in contact with mobile
phase when all the mobile phase is used up, the piston returns quickly by pneumatic means, thus
refilling the chamber. The advantage of this is pulse less flow and unlimited solvent capacity.
POSITIVE DISPLACEMENT (SYRINGE) PUMP
Syringe  pump is  a  single stroke displacement  pump which  has  to  be  refilled  after  it
displaces the whole syringe volume. On the other hand, a syringe pump does not have any flow
and pressure pulsations compared to the reciprocating pump. A screw fed drive connected to a
stepping  motor  actuates  the  piston  inside  the  chamber.  For  the  micro-HPLC  applications  a
syringe pump allows for the maintaining of a constant flow at the micro liter per minute flow rate
range and requires no check valves.
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Mixing unit is used to mix solvents in different proportions and pass through the column. The
two primary methods of blending the mobile phase components are Low Pressure Mixing and
High Pressure Mixing.
In an isocratic separation, mobile phase is prepared by using pure solvent or mixture of
solvents, i.e., solvent of same eluting power or polarity is used. But in gradient elution technique,
the polarity of the solvent is gradually increased and hence the solvent composition has to be
changed. Hence a gradient controller is used when two or more solvent pumps are used.
INJECTORS
Injectors for liquid chromatographic systems should provide the possibility of injecting
the liquid sample within the range of 0.1 to 100 ml of volume with high reproducibility and
under high pressure (up to the 4000 psi). They should also produce minimum band broadening
and minimize possible flow disturbances. Generally, the most useful and widely used sampling
device for modern LC is the micro sampling injector valve.
RHEODYNE INJECTOR
Because of their superior characteristics, valves are now used almost to the exclusion of
syringe  injection.  With  these  sampling  valves,  samples  can  be  introduced  reproducibly into
pressurized columns without significant interruption of flow, even at elevated temperature.
AUTOMATIC INJECTORS
With commercially available automatic sampling devices, large number of samples can
be routinely analyzed by LC without operator intervention. Such equipment is popular for the
analysis  of  routine  samples  (e.g.,  quality  control  of  drugs),  particularly  when  coupled  with
automatic data-handling systems. Automatic injectors are indispensable in unattended searching
(e.g.,  overnight)  for  chromatographic  parameters  such  as  solvent  selectivity,  flow  rate,  and
temperature optimization. Most of the auto samplers have a piston metering syringe type pump
to suck the reestablished sample volume into a line and then transfer it to the relatively large loop
(~100 ml) in a standard six-port valve. The simplest auto samplers utilize the special vials with
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pressurization caps. A special plunger with a needle, push the cap down to the vial and displace
the sample through the needle into the valve loop. Most of the auto samplers are microprocessor
controlled and can serve as a master controller for the whole instrument.
COLUMNS
HPLC column are made up of stainless steel or glass, which differs in length and inside
diameter depending on the application. The two types of columns are Analytical column and
Preparative column. Standard analytical columns are 4-5 mm in internal diameter and 10-30 cm
in length. The particle size used ranges from 5-10  pm. Preparative columns are 20-50 mm in
internal diameter and 20-100 cm in length. The particle size used ranges from 37-50 m.
PRE COLUMN FILTERS: (Guard Column)
Prevents the contamination of the expensive analytical columns with fine particles that
can eventually clog the mobile phase flow. Made up of Porous stainless Frit (0.5 – 2  m) or a
little piece of sacrificial column.
Functional  group present in stationary phase depends on the type of chromatographic
separation. In normal phase mode it contains the silanol groups (OH group), in reverse phase
mode  it  contains  Octyl  Decyl  Silane  (ODS)  column,  Octyl  column,  Butyl  column,  Nitrile
column,  Amino  column,  Base  deactivated  silane  (BDS)  column  etc.,  for  other  modes  of
chromatography, ion exchange, gel columns, and chiral columns are available.
DETECTORS
The function of the detector in HPLC is to monitor the mobile phase as it emerges from
the column. Generally, there are two types of HPLC detectors, bulk property detectors and solute
property detectors. 
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a) Bulk property detectors: 
These detectors are based on differential measurement of a property, which is common to
both  the  sample  and  the  mobile  phase.  Examples  of  such  detectors  are  refractive  index,
conductivity and dielectric constant detectors.
b) Solute property detectors:
Solute  property detectors  respond  to  a  physical  property  of  the  solute,  which  is  not
exhibited by the pure mobile phase. These detectors measure a property, which is specific to the
sample,  either with or without the removal  of  the mobile phase before the detection.  Solute
property detectors which do not require the removal of the mobile phase before detection include
spectrophotometric (UV or UV-Visible) detector, fluorescence detectors, polarographic, electro-
chemical  and  radio  activity  detectors,  where  flame  ionization  detector  and  electron  capture
detector both require removal of the mobile phase before detection.
RECORDERS AND INTEGRATORS
Recorders are used to record the responses obtained from detectors after amplification, if
necessary. They record the baseline and all the peaks obtained, with respect to time. Retention
time for all the peaks obtained, with respect to time. Retention time for all the peaks can be
found out from such recordings, but the area of individual peaks cannot be known.
Integrators  are improved version of  recorders  with  some data processing capabilities.
They can record the individual peaks with retention time, height and width of peaks, peak area,
percentage of area, etc. integrators provide more information on peaks than recorders. Nowadays
computers  and  printers  are  used  for  recording  and  processing  the  obtained  data  and  for
controlling several operations.
APPLICATIONS IN PHARMACEUTICAL ANALYSIS
The sample or solute is analyzed quantitatively in HPLC by either peak height or Peak
area measurements. Peak areas are proportional to the amount of constant rate. Peak heights are
proportional  to  the  amount  of  material  only  when  peak  width  is  constant  and  are  strongly
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affected  by  the  sample  injection  techniques.  Once  the  peak  height  or  the  peak  areas  are
measured, there are five principle evaluation methods for quantifying the solute.
Calibration by Standards
Calibration curves for each component are prepared from pure standards, using identical
injection  volumes  and  operating conditions  for  standards  and  samples.  The concentration of
solute is read from its curve if the curve is linear.
Concentration of solute    =     Proportionality Constant (k) x Area
In this evaluation method only the area of the peaks of interest is measured. Relative
response factors must be considered when converting areas to volume and when the response of
a given detector differs for each molecule type of compounds.
Internal Standard Method
In this technique a known quantity of the internal standard is chromatographed and area
Vs concentration is ascertained. Then a quantity of the internal standard is added to the raw
sample prior to any sample pretreatment or separation operations.
The peak area of the standard in the sample run is compared with the peak area of the
standard run separately. This ratio serves as a correction factor for variation in sample size, for
losses in any preliminary pretreatment operations or for incomplete elution of the sample. The
material selected for the internal standard must be completely resolved from adjacent sample
components  must  not  interfere  with  the  sample  components  and  must  never  be  present  in
samples.
Standard Addition Method
If only few samples are to be chromatographed, it is possible to employ the method of
standard addition(s). The chromatogram of the unknown is recorded, then a known amount of
analyte(s) is added and the chromatogram is recorded using same reagents, instruments and other
conditions. From the increase in the peak area (or peak height), the original concentration can be
computed by interpolation.
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The detector response must be a linear function of analyte concentration and yield no
signal at zero concentration of the analyte. Sufficient time must elapse between addition of the
standard and actual analysis to allow equilibrium of added standard with any matrix interfering.
A correction for dilution must be made if the amount of standard added changes the total
sample volume significantly. It  is always advisable to check the result by adding at least one
other standard.
External Standard Method
  It employs a separate injection of a fixed volume of sample and standard solution. The
peaks are integrated and concentration is calculated.
The selection of suitable chromatographic (HPLC) system for a given mixtures of solutes
cannot be made with certainty and must be confirmed by experiment. If the chemical nature of
the sample components is  known, then the phase system can be selected from the literature
references. If nothing is known about the chemical nature of sample, then the sample solubility
will give some indication as to which chromatographic method to employ.
Best column, best mobile phase, best detection wavelength, efforts in their selection can
make a world of difference while developing HPLC method for routine analysis. Determining
the ideal  combination of these factors assures faster delivery of desired results and validated
method for separation.
INTRODUCTION TO METHOD DEVELOPMENT (3)
HPLC method  development  for  the  analysis  of  mixtures  of  substances  is  a  task that
usually requires much expertise. It  is also extremely time-consuming. In spite of advances in
chromatographic theory, HPLC method development is still based mainly on “trial and error”.
The development of any new or improved method usually tailors existing approaches and
instrumentation  to  the  current  analyte,  as  well  as  to  the  final  needs  or  requirements  of  the
method. Method development in Liquid chromatography usually requires selecting the method
requirements and deciding what type of instrument to utilize and why. In the development stage,
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decisions regarding choice of column, mobile phase, detectors, and method of quantitation must
be addressed.
The following are the reasons for developing new methods of analysis:
• The method may not be suitable for particular analyte.
• Existing method may be too error or contamination prone or they may be unreliable.
• Existing method may be too expensive, time consuming or energy intensive, or they may
not be easily automated.
• Existing method may not provide adequate sensitivity or analyte selectivity in samples of
interest.
• Newer instrumentation and techniques may have evolved that provide opportunities for
improved methods, including improved analyte identification or detection limits, greater
accuracy or precision or better return on investment.
• There may be a need for an alternative method to confirm, for legal or scientific reasons,
analytical data originally obtained by existing methods.
The goals of the method are necessary to translate into a method development design. Goals for
new or improved analytical methods might include the following.
• Qualitative identification of the specific analyte(s) of interest providing some structural
information to confirm "general behavior"(e.g. retention time, colour change, pH etc.,
• Quantitative determination, at trace levels when necessary that is accurate, precise, and
reproducible in any laboratory setting when performed according to established procedures.
• Ease of  use,  ability to be automated,  high sample throughput,  and rapid sample turn
around time.
• Decreased  cost  per  analysis  from using  simple  quality  assurance  and  quality  control
procedures.
• Preparation of samples that minimize time, effort, materials, and volume in of sample
consumed.
  The first  step in  the  method development  process  is  to  decide which chromatographic
method will be used. Choices may be as diverse as GC, LC or superficial-fluid chromatography
(SFC), Normal – phase (NPLC) or reverse phase chromatography (RPLC), and ion-exchange
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(IEC) or ion-pairing chromatography (IPC). Within RPLC, silica modified with octadecyl, Octyl
or short alkyl chains or with phenyl, amino or Cyano groups may form the stationary phase. This
shows that there is a 'selection tree' for chromatographic systems. For each stationary phase there
may still  be  a  number of  different  mobile  phases  from which  to  select  the most  promising
starting conditions (or the best 'first guess').
Steps involved in HPLC Method Development:
Step-1:
Method Selection:  The  first  step  in  developing  an  HPLC method  is  to  always  consult  the
literature to ascertain whether the separation has been previously performed and if  so, under
what conditions-this will save time, doing unnecessary experimental work. The information from
literature should contain.
• Solubility  profile  –  which  provides  the  information  about  the  solubility  of  drug
substances in different solvents and at different pH conditions.
• Analytical profile – which provides the information about the analytical profile of the
drug substance, impurities and degradation products.
• Stability profile – which provides the information about the stability profile of the drug
substance with respect to storage conditions.
Step-2
Retention Optimization: This step determines the optimum conditions to adequately retain all
analytes that ensures no analyte has a capacity factor limits not less than 0.5 and not greater than
10-15.
• Poor retention could result in peak overlapping.
• Excessive retention leads to long analysis time and broad peaks with poor detection.
Step-3
Selectivity Optimization: The mobile phase and stationary phase compositions need to be taken
into account to achieve adequate selectivity (peak spacing). To minimize the number of trail
chromatograms involved,  only the  parameters  that  are  likely to  have  a  significant  effect  on
selectivity in the optimization must be examined. To select these, the nature of the analytes must
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be considered. It is much easier to optimize mobile phase parameters than to optimize stationary
phase. 
Step-4
System Optimization: This is used to find the desired balance between resolution and analysis
time after satisfactory selectivity has been achieved. The parameters involved include column
dimensions,  column packing,  particle  size and flow rate.  These parameters  may be changed
without affecting capacity factors or selectivity. 
Step-5
Method Validation:  Proper validation of  analytical  methods is  important  for pharmaceutical
analysis when ensuring of the continuing efficacy and safety of each batch manufactured relies
solely  in  the  determination  of  quality.  Method  Validation  is  generally  a  one-time  process
performed after the method has been developed to demonstrate that the method is scientifically
sound and that serves the intended analytical purpose. 
METHOD VALIDATION PARAMETERS (4)
ICH for registration of pharmaceuticals has developed consensus text on validation of
analytical procedures which include,
Specificity
            It is the ability to asses’ unequivocally the analyte in the presence of components which
may be expected to present. Lack of specificity of an individual analytical procedure may be
compensated by other supporting analytical procedures.
           Procedures used to demonstrate specificity will depend on the intended objective of the
analytical procedures.
           It  is not always possible to demonstrate that analytical procedures is specific for a
particular analyte (complete discrimination).In this case a continuation of two or more analytical
procedure is recommended to achieve necessary level of discrimination.
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Accuracy
          Accuracy of an analytical procedure expresses the closeness of agreement between the
value which is accepted either as conventional true value or on an accepted reference value and
the value found.
Assay
Active substance
Several methods of determining accuracy are available
a. Application  of  analytical  procedures  to  an  analyte  of  known  purity  (Eg.Reference
material).
b. Comparison of the results of the proposed analytical procedures with those of a second
well-characterized procedure, the accuracy of which is stated and /or defined.
c. Accuracy may be inferred once precision linearity and specificity has been established.
Medicinal products - methods include
a. Application of analytical procedure to synthetic mixtures of product components to
which known quantities of substance to be analyzed have been added.
b. In case where it is impossible to obtain samples of all product components, it may be
acceptable either to add known quantities of the analyte to the product or to compare
the  result  obtained  from a  second  well  characterized  procedure,  the  accuracy of
which is stated and defined.
Impurity (Quantification) (5)
           Accuracy should be assessed on sample (substance/products) spiked with known amount
of impurities 
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Precision
           The precision of analytical procedure express the closeness of agreement between a series
of  measurement  obtained  from  multiple  sampling  of  the  same  homogeneous  sample  under
prescribed conditions. Precision of an analytical procedure is usually expressed at the variance,
standard deviation or coefficient of variation of series of measurements.
Repeatability
            Express the precision under the same operating conditions over a short interval of time.
Repeatability is also termed as intra assay precision.
            It should be assessed using a minimum of nine determinations covering the specified
range  for  the  procedure  (Eg.  three  concentration  /three  replicates  each)  or  a  minimum  of
determination at 100% of the test concentration.
Intermediate precision
          The  extent  to  which intermediate  precision should be established  depends on the
circumstances under which the procedure is intended to be used. Typical variations to be studied
include days, analysts, equipments etc.
It  is not necessary to study these effects individually.  The use of experimental design
(matrix) is encouraged.
Reproducibility
          Reproducibility is assessed by means of an interlaboratory trial. Reproducibility should be
considered in case of the standardization of an analytical procedure, for instance of procedures in
pharmacopoeias.
Linearity &Calibration Curve
Linearity of an analytical produce is its ability (within a given range) to obtain test results
which are directly proportional to the concentration of analyte in the sample.
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Linearity should be evaluated by visual inspection of a plot of signals as a function of
analyte concentration or content. If there is a linear relationship test results should be evaluated
by appropriate statistical methods for example, by calculation of a regression line by the method
of  least  squares.  Therefore  data  from  regression  line  itself  may  be  helpful  to  provide
mathematical  estimates of the degree of linearity.  For  linear ranges  the deviations should be
equally distributed between positive and negative values.
Range
Range  of  an  analytical  procedure  is  the  interval  between  the  upper  and  lower
concentration (amounts) of analyte in the sample including these concentrations for which it has
been demonstrated that the analytical procedure has a suitable level of precision accuracy and
linearity.
The following minimum specified ranges should be considered.
 For the  assay of  an  active substance  or  a  finished  product  –  80 –  120% of  the  test
concentration.
 For the content uniformity –   70 – 130% of test.
 For dissolution testing, 20% over specified range.
Eg. If the specifications for the controlled released product cover a region from 20% after
the 90% after 24hrs, the validated range – 0-110% of label claim.
 For the determination of an impurity.
 Reporting level of impurity to 12% of specifications.
Limit of Detection
Several  approaches  depending  on  whether  the  procedure  is  a  non-instrumental  or
instrumental are available.
Based on visual Evaluation
The detection limit is determined by the analysis of samples with known concentration of
analyte and by establishing minimum level.
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Based on signal to noise ratio
This approach can only be applied to analytical procedure which exhibit base line noise.
Determination of signal to noise ratio is performed by comparing measured signals from samples
with known low concentrations  of  analyte with  those of  blank samples  and establishing the
minimum concentration at which the analyte can be detected.
Based on the standard deviation of the response and the slope:
Detection Limit (DL) = 3.3 σ/s
Where σ = the standard deviation of the response
S = the slope of the calibration curve
 S is calculated from calibration curve of analyte
Based on standard deviation of Blank
Measurement  of  the  magnitude  of  analytical  background  response  is  performed  by
analyzing an appropriate  number of  blank samples  and calculating the standard deviation of
these responses.
Based on calculation curve
            A specific calibration curve should be studied using samples containing an analyte in the
range  of  DL and  QL.  The  residual  standard  deviation  of  a  regression  line  or  the  standard
deviation of y-intercept of regression line may be used as the standard deviation
Recommended Data
The detection limit and the method used for determining the detection limit should be
presented.
Eg. In case of visual method relevant chromatogram is acceptable for justification.
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In  case  of  calculation  or  extrapolation  method,  it  must  be subsequently validated  by
independent  analysis  of  suitable  number  of  samples  known  to  be  near  or  prepared  at  the
detection limit.
Limit of Quantification
Several  approaches  are  there  based  on  whether  the  procedure  is  instrumental  /  non
instrumental approaches other than are also acceptable.
 Based on Visual Evaluation
            Visual evaluation may be used for non-instrumental methods but may also be used with
instrumental methods.  The detection limit is determined by the analysis of samples with known
concentrations of analyte and be establishing the minimum level at which the analyte can be
reliable detected. The quantitation limit is generally determined by the analysis if samples with
known concentrations of analyte and by establishing the minimum level at which the analyte can
be quantified with acceptable accuracy and precision. 
 Based on signal to noise ratio
             This approach can only be applied to analytical procedures, which exhibit baseline noise.
Determination of the signal-to-noise ratio is  performed by comparing measured signals from
samples with known low concentrations of analyte with those of blank samples and establishing
the minimum concentrations at which the analyte can be reliably detected and quantified.  A
signal-to-noise  ratio  between  3  or  2:1  is  generally  considered  acceptable  for  estimating  the
detection limit and a ratio of 10:1 for quantitation.
                                     A typical to noise ratio is 10:1.
Based on the standard deviation of the response and the slope
The quantization limit (QL) may be expressed as
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Where σ = the standard deviation of the response
           S = slope is obtained from calibration curve 
          The estimate may be curried out by various methods
Based on the Standard Deviation of the Blank
              Measurement of the magnitude of analytical background response is performed by
analyzing an appropriate  number of  blank samples  and calculating the standard deviation of
these responses.                   
Based on the calibration curve  
A specific calibration curve should be studied using samples containing an analyte in the
range  of  DL and  QL.   The  residual  standard  deviation  of  a  regression  line  or  the  standard
deviation of y-intercepts of regression lines may be used as the standard deviation.
Robustness
It is depends on the type of procedure under study. It should show the reliability of an
analysis with respect to deliberate variations in method parameters.
Examples of typical variations are
 Stability of analytical solutions
 Extraction time
In case of liquid chromatography, examples of typical are
 Influence of variation of pH in a mobile phase
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 Influence of variation in mobile phase composition
 Different columns
 Temperatures
 Flow rate
In case of gas chromatography
 Different columns
 Temperature
 Flow rate
Ruggedness
       Degree of reproducibility of test results obtained by analyzing the same sample under variety
of normal test conditions. Such as different
 Analysts
 Instruments
 Days
 Reagents
 Column TLC plates
Comparison of reproducibility of test results to be precision of assay is the direct measure of
ruggedness of the method.
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2. DRUG PROFILE
                                               TENOFOVIR
2.1 Chemical properties:
IUPAC name: ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphoric acid
Molecular Weight: 287.213 g/mol
Molecular Formula: C9H14N5O4P
STRUCTURE:
2.2 Physical Properties:
Tenofovir  is a white to off-white crystalline
powder with a solubility of 13.4 mg/mL in distilled water
at  25  °C.  It has  an  octanol/phosphate  buffer  (pH  6.5)
partition coefficient (log p) of 1.25 at 25 °C.
2.3 Pharmacokinetic data:
Absorption: The  oral  bioavailability  in  fasted  patients  is  approximately  25%.
Administration of food (high fat meal containing 40 to 50% fat) increases the
oral bioavailability, with an increase in the AUC of approximately 40%.
Protein binding:     < 0.7% to human plasma proteins and < 7.2% to serum  proteins.
Half-life:                   Approximately 17 hours.
Excretion:               Excreted renally by glomerular filtration and active tubular secretion
2.4 Metabolism:
Tenofovir inhibits the activity of HIV reverse transcriptase by competing with the
natural substrate deoxyadenosine 5’-triphosphate and after incorporation into DNA by DNA
chain  termination.  Specifically,  the  drugs  are  analogues  of  the  naturally  occurring
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deoxynucleotides needed to  synthesize the viral  DNA and they compete with the natural
deoxynucleotides for incorporation into the growing viral DNA chain. However, unlike the
natural deoxynucleotides substrates, NRTIs and NtRTIs (nucleoside/tide reverse transcriptase
inhibitors) lack a 3'-hydroxyl group on the deoxyribose moiety. As a result, the next incoming
deoxynucleotide cannot form the next 5'-3' phosphodiester bond needed to extend the DNA
chain. Thus, when an NRTI or NtRTI is incorporated, viral DNA synthesis is halted, a process
known as chain termination. All NRTIs and NtRTIs are classified as competitive substrate
inhibitors.
2.5 Uses:
Tenofovir is used with other medications to help control  HIV infection, thereby improving
quality of life. It helps to decrease the amount of HIV in  body so  immune system can work
better.  It  also lowers  risk of getting HIV disease complications (such as new infections,
cancer).  Tenofovir  belongs  to  a  class  of  drugs  known as  nucleotide reverse  transcriptase
inhibitors (NRTIs).Tenofovir is not a cure for HIV and it does not prevent the spread of HIV
to others through sexual contact or blood contamination (such as sharing used needles).
Tenofovir is also used to treat  a certain type of liver infection called chronic hepatitis  B
infection. It  helps to decrease the amount of hepatitis B virus in body by interfering with
virus growth.
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3. REVIEW OF LITERATURE
Kandagal  P.B  et  al[6],  2008   reported  A simple  reverse-phase  high-performance  liquid
chromatographic method for  the determination of  tenofovir disoproxil  fumarate (TDF) in
pharmaceutical formulations and human plasma samples. Piroxicam (PRX) was used as an
internal standard. The assay of the drug was performed on a CLC C18 (5 µ, 25 cm x 4.6 mm
i.d.) with UV detection at 259 nm. The mobile phase consisted of acetonitrile-water mixture
in the ratio of 75:25 and a flow rate of 1 ml/min was maintained. The standard curve was
linear over the range of 0.2-10 µg/ml (r2 = 0.9966). Analytic parameters have been evaluated.
Within-day and between day precision as expressed by relative standard deviation was found
to be less than 2%. The method has been applied successfully for the determination of TDF in
spiked human plasma samples and pharmaceutical formulations.
Rezk NL et al[7],2005 described an accurate, sensitive and simple reverse-phase (RP) high-
performance  liquid  chromatography  (HPLC)  method  for  the  simultaneous  quantitative
determination of emtricitabine and tenofovir in human blood plasma is described. Using 200
µl of plasma and BOND ELUT-C18 Varian columns, the solid phase extraction (SPE) method
results in a clean baseline and high extraction efficiencies (100% for emtricitabine and 98.6%
for tenofovir). An Atlantis trade mark dC18 analytical column was used along with an 18 min
linear gradient elution of phosphate buffer (pH 5.7) and methanol to provide sharp peaks for
emtricitabine at 280 nm, tenofovir at 259 nm and for the internal standard 2',3'didoxyuridine
(DDU) at 262 nm. The method was validated over the range of 10-10,000 ng/ml for both
analytes, and was accurate (average accuracies of three different concentrations ranged from
98  to  105%  for  emtricitabine  and  97  to  103%  for  tenofovir)  and  precise  (within-  and
between-day precision ranged from 1.7 to 3.7% and 3.7 to 5.2%, respectively). This method
could  be  suitable  for  use  in  clinical  pharmacokinetic  studies  and  is  nimble  enough  for
therapeutic drug monitoring.
El Barkil M et al  [8], 2003 developed a sensitive high-performance liquid chromatography
method coupled to UV and single mass spectrometry (MS) detection  for the determination of
tenofovir  in  human  plasma.  A solid  phase  extraction  procedure  (Bond-Elut  C18 Varian
cartridges) provided high extraction efficiency (91% for tenofovir and 68.8% for the internal
standard, 3-methylcytidine). An atlantis-dC18 analytical column was used with an isocratic
mode elution of a mixture (pH 2.5) of ammonium acetate/methanol (98.5:1.5, v/v). Detection
was performed at 260 nm and by using the ion at m/z 288. The signals from both detectors
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were validated over the range of 10-1000 ng/ml and were found to be linear, accurate and
precise. At the lowest limit of quantification, 10 ng/ml for UV and 5 ng/ ml for MS, the
average coefficient of variation was 6.9 and 3.9%, respectively. The potential of this validated
method for clinical studies was investigated by analysing more than 170 samples from HIV-
infected adult patients. A good correlation was observed between the results obtained with
both detectors. However, in several cases discordant results were observed between UV and
MS detections. Therefore, tenofovir could  suffered from interferences using either UV or
single MS detection. They concluded that  the double detection allowed to obtain a  more
specific  quantification  of  tenofovir.  The  present  assay was  sound  and could  be  used  for
therapeutic drug monitoring allowing a higher reliability of the results which are transmitted
to the medical team.
Jullien  V  et  al, 2003[9] developed  a  sensitive  high-performance  liquid  chromatography
method  with  spectrofluorimetric  detection  for  the  determination  of  tenofovir   in  human
plasma. After precipitation of 200 µl of plasma samples by methanol and evaporation of the
supernatant,  fluorescent  derivatized compounds  were  obtained  by a  40-min incubation at
80ºC with chloroacetaldehyde 0.34% at pH 4.5. The assay was performed isocratically using
5  mM  Na2HPO4 (pH  6),  containing  tetrabutylammonium  (TBA)  chloride  5  mM,  and
acetonitrile  (85:15,  v/v)  as  mobile  phase  and  a  Cluzeau  C8   plus  satisfaction  column
maintained at 35ºC. Detection was performed at excitation and emission wavelengths set at
236  and  420  nm,  respectively.  In  these  conditions,  tenofovir  could  be  separated  from
adefovir,  the  internal  standard  and  endogenous substances.  The method was found to  be
linear  and  had been validated  over  a  concentration range  of  5-1000 µg/ml.  The average
coefficient of the limit of quantification (5 µg/ml ) was 5.38% and at this concentration, a
signal-to-noise ratio of 500 was measured.
Sentenac S et al, 2006[10]  reported a new high-performance liquid chromatography assay for
the determination of tenofovir, a nucleotide analogue, in plasma. A solid-liquid extraction
procedure was coupled with a  reversed-phase HPLC system. The mobile  phase consisted
of  Na2HPO4 buffer,  tetrabutyl  ammonium hydrogen  sulfate  and  acetonitrile  for  different
elution through a C18 column with UV detection. This method proved to be accurate, precise
and linear between 10 and 4000 ng/ml. This method was applied to determine trough levels
of tenofovir in 11 HIV-infected patients with virologic failure under multiple antiretroviral
therapy. This method was also successfully applied to a pharmacokinetic study in an HIV
infected patient with renal failure.
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Delahunty  T  et  al,  2005[11] developed  and  validated   an  LC/MS/MS  method  for  the
determination  of  tenofovir  (TNF)  with  the  beta  anti  coagulated  human  plasma  matrix.
Heparin-treated plasma and serum matrices were also validated. After addition of adefovir as
an  internal  standard,  trifluoroacetic  acid  was  used  to  produce  a  protein-free  extract.
Chromatographic  separation  was  achieved  with  a  Polar-RP Synergi,  2.0  mm x  150  mm,
reversed-phase analytical column. The mobile phase was 3% acetonitrile/1% acetic acid, aq.
Detection of TNF and the internal standard was achieved by ESI MS/MS in the positive ion
mode using 288/176 and 274/162 transitions, respectively. This method was linear from 10 to
750 ng/ml with a minimum quantifiable limit of 10 ng/ml when 250 microl aliquots were
analyzed.  The  usefulness  of  this  LC/MS/MS  method  to  routinely  monitor  plasma
concentrations of TNF was demonstrated along with its ability to assist in the performance of
pharmacokinetic studies.
Colombo S et al, 2006[12] reported an HPLC method for the determination of the novel non-
peptidic HIV protease inhibitor tipranavir (TPV) in human plasma by off-line solid-phase
extraction (SPE) followed by HPLC coupled with UV-diode array detection (DAD). After
viral inactivation by heat, the plasma was diluted with phosphate buffer (pH 7) and subjected
to a SPE on a C18 cartridge. Matrix components were eliminated with a solution of 0.1%
H3PO4 solution neutralised to pH 7 and TPV was eluted with MeOH. The resulting eluate was
evaporated and reconstituted in 100 µl MeOH/H2O 50/50. A 40 µl volume was injected onto
a  Nucleosil  C18 AB column and TPV was analysed  by UV detection at  201 nm using a
gradient elution program constituted of MeCN and phosphate buffer adjusted to pH 5.12 and
containing  0.02%  sodium  heptanesulfonate.  The  calibration  curves  were  linear  up  to  75
µg/ml, with a lower limit of quantification of 0.125 microg/ml. The mean absolute recovery
of TPV is 77.1+/-4.0%. This method was precise with mean inter-day coefficient of variations
(CVs) within 2.2-3.4%, and accurate (range of inter-day deviations from 0.7 to 1.2%). This
method had been validated and is currently applied to the monitoring of TPV plasma levels in
HIV patients.
King T et al, 2007[13]  developed a LC -MS-MS method to facilitate the evaluation of drug
safety,  virologic activity and pharmacokinetics.  An anion exchange isolation of tenofovir-
diphosphate (TFV-DP) from human peripheral blood mononuclear cells (hPBMCs), coupled
with dephosphorylation, desaltation and detection was reported . hPBMCs were harvested
from whole blood, lysed and a suspension of intracellular tenofovir moieties was produced.
TFV-DP  was  isolated  from  TFV-monophosphate  (TFV-MP)  and  tenofovir  (TFV)
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dephosphorylated with acid phosphatase to form TFV and then desalted and concentrated.
The lower limit of quantitation (LLOQ) of the method is 10 fmol per million cells with 5
million hPBMCs used.
Bennetto-Hood Cet al, 2009[14]  repoted a sensitive and specific method for the quantitation
of tenofovir (TFV) in human plasma by liquid chromatography/electrospray ionization mass
spectrometry. Plasma samples were prepared by solid-phase extraction performed on Waters
Oasis  cation-exchange  cartridges  (30  mg).  Chromatographic  separation  was  performed
isocratically on a reversed-phase Waters Atlantis  dC18 column (2.0x100 mm, 3 mm). The
mobile phase consisted of a hydroxylamine/acetic acid buffer (pH 6.75) and methanol (93:7,
v/v).  The  acquisition was performed in  selected  ion monitoring  mode for  the protonated
molecular ions [M+H]+ of m/z 288.2 for TFV and 212.2 for the internal standard, zalcitibine.
This  method  was  fully  validated  to  determine  its  specificity,  recovery,  linearity  and
sensitivity, accuracy and precision. The analytical range was set at 1-750 ng/ml using a 200
µl  plasma  sample  with  a  mean  coefficient  of  determination  (r2)  of  0.9969.  The  mean
accuracies for the calibration standards ranged from -5.0 to 4.3%, while the precisions were
within 1.2 and 6.4%. Intra-assay and inter-assay mean accuracies for three quality control
concentrations (2, 60, and 600 ng/ml) ranged from -6.1 to 10.7%, while the precisions were
within 1.3 and 9.1%. TFV was shown to be stable under normal storage and assay conditions;
no degradation was seen when stored at -20 degrees C or -80 degrees C for up to 6 months,
and after 16 h at room temperature in the injection matrix. The present method provided an
accurate, precise, and sensitive tool for TFV quantitation and was successfully applied to an
external proficiency-testing program and pharmacokinetic analysis.
Yadav  M  et  al,2009[15] developed  a  simple,  specific,  and  high  throughput  liquid
chromatography tandem mass  spectrometry method for  the  determination  of  tenofovir  in
human plasma using adefovir as internal standard. Plasma samples were prepared by solid-
phase extraction of the analyte and internal standard using Waters Oasis MCX cartridges (1
cc, 30 mg). The chromatographic separation was achieved on a reversed-phase Chromolith,
C18 analytical column (100 mmx4.6 mm, 5 µm) under isocratic conditions. The mobile phase
consisted of 0.5% formic acid in water and acetonitrile (90:10, v/v) to give a run time of 1.8
min. The protonated precursor-->product ion transitions for tenofovir and IS were monitored
on a triple quadrupole mass spectrometer operating in the multiple reaction monitoring and
positive ion mode. The fragmentation pathways for tenofovir were studied by varying the
collision energy (5-55 V) using nitrogen as CAD gas. A linear dynamic range of 3.1-1002.0
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ng/ml was established using 0.2 ml plasma sample. The method was fully validated for its
sensitivity,  selectivity,  accuracy,  precision,  matrix  effect,  recovery,  stability  and  dilution
integrity.  It  was  applied  to  a  bioequivalence  study  in  43  human  subjects  after  oral
administration of 300 mg tablet formulation under fasting conditions.
Ahmed  Z et al,2009[16]  developed and validated a simple, selective, linear, accurate and precise
RP-HPLC  method  for  routine  analysis  of  tenofovir  disoproxil  in  bulk  and  in  pharmaceutical
formulation. Isocratic elution at  a flow rate of  1.0 mL/min was employed on a Thermo Hypersil
HIGH PURITY C18 reversed-phase column (150 mm x 2.1 mm i.d., 5 mu m) at ambient temperature.
The mobile phase consisted of acetonitrile and 0.05 M phosphate buffer pH 6.0 (50: 50, v/v). The UV
detection wavelength was 260 nm and 20 µl of sample was injected. The retention time for tenofovir
disoproxil  was  4.45  min.  The  sensitivity,  accuracy,  precision,  robustness,  stability,  specificity,
selectivity and system suitability parameters were  validated for this method.
Guo  J  et  al,2002[17] reported  a  simple,  specific,  sensitive  LC/MS/MS  method  for  the
quantitation  of  tenofovir  (TFV) in  monkey plasma.  After  the  addition  of  adefovir  as  an
internal  standard  (IS),  methanol  was  used  to  produce  a  protein-free  extract.  Isocratic
chromatographic  separation  was  performed  on  a  reverse-phase  Discovery  C(18)  column
(4.6×250 mm, 5 µm). The mobile phase consisted of methanol-water-formic acid (20 : 80 :
0.5, v/v/v). Detection of TFV and the IS was achieved with electrospray ionization (ESI)-
MS/MS in the positive ion mode using 288/176 and 274/162 transitions respectively. The
analytical range was set at 0.005-1.250 µg/ml using a 200 µl plasma sample. The intra- and
inter-day precision values were less than 11.4% and accuracy ranged from 0.4 to 2.9% in all
quality  control  samples.  This  method  was  fully  validated  for  its  sensitivity,  selectivity,
accuracy,  precision, matrix effect, recovery and stability. Due to the high polarity of TFV, the
major  challenge  was  to  circumvent  ion  suppression  when  quantitating  the  plasma
concentration  of  TFV  using  the  LC/MS/MS  method.  Moreover,  it  was  found  that  the
reconstitution solvents of the dried residue had a significant impact on LC peak shapes. This
validated method was successfully applied to a bioequivalence study in 6 monkeys after the
oral administration of two ester prodrugs of TFV (equivalent to TFV 20 mg/kg). This method
permitted laboratory scientists with access to the appropriate instrumentation to perform rapid
TFV determination.
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4. AIM AND PLAN OF THE STUDY
4.1 AIM AND SCOPE:
Tenofovir is relatively a newer antiretroviral drug and used in the treatment of HIV. 
For quantification of Tenofovir in tablet formulation, very few HPLC methods were
available.
Hence the aim of present work is to develop simple and validated RPHPLC method
by isocratic mode for the quantification of Tenofovir in bulk and it’s formulation.
4.2 PLAN OF WORK:
The plan of present work is as follows:
Method Development
 Selection of wavelength 
 Selection of initial separation conditions  
 Selection of mobile phase (pH, peak modifier, solvent strength, ratio
and flow rate)
 Nature of the stationary phase
 Selection of separation method and agent
Validation of the developed method
            The developed method has to be validated by using the various validation
parameters such as, 
 Accuracy
 Precision
 Linearity and of detection (LOD) / Limit of quantitation (LOQ)
 Selectivity / Specify
 Robustness / ruggedness
 System suitability.
Km college of pharmacy
Page 30
Dept of Analysis
5. METHODOLOGY
5.1 MATERIALS AND INSTRUMENTS USED
a) Drug samples:
Tenofovir pure  drug sample was obtained from Hetero labs, Hyderabad and tablet
dosage form  belongs to Ranbaxy pharma(Tentide - 300 mg).
b) Chemicals and Solvents used:
S. No Name Grade
1. Methanol Merck (HPLC Grade)
2. KH2PO4  HPLC Grade
3. Acetonitrile Merck (HPLC Grade)
4. Tetrahydrofuron AR grade
c) Instruments used:
S. No Name Model
1. HPLC Peak 7000
2. Digisun pH meter 2001
3. Eletronic balance ELB 300
4. UV Spectrophotometer 2201 UV-VIS
5.2  OPTIMIZATION  OF  CHROMATOGRAPHIC  CONDITIONS  FOR  THE
ESTIMATION OF TENOFOVIR
The present work is for the development of the RP-HPLC method for the Tenofovir
and its validation.
5.2.1 Selection of wavelength
An UV spectrum of 100µg/ml Tenofovir in methanol was recorded by scanning in the 
range of 240 nm to 270 nm. From the absorbance data 260 nm was selected . At this 
wavelength Tenofovir showed good absorbance table.1.
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Fig 2: UV Absorbance graph.
   
 Table 1: Data of Absorbance
S. No. Wavelength Absorbance
1. 255 0.568
2. 256 0.632
3. 257 0.699
4. 258 0.742
5. 259 0.781
6. 260 0.902
7. 261 0.745
8. 262 0.721
9 263 0.632
5.2.2 Selection of chromatographic method
Proper  selection  of  the  method  depends  upon  the  nature  of  the  sample
(ionic,ionisable,neutral molecule), its molecular weight and solubility. The drug selected in
the present study is  polar in nature and hence reverse phase or ion-pair or ion–exchange
chromatography method may be used. The reverse phase HPLC was selected for the initial
separations because of its simplicity and suitability.
Initial separation conditions
Standard solution : 100 µg/ml of Tenofovir in HPLC grade methanol.
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Equipment
System      : PEAK7000 isocratic HPLC
Pump         : PEAK 7000 delivery system
Detector     : Diode array detector
Injector      : Rheodyne 7725i with 20 µl loop
Trail 1:
       Chromatographic conditions: 
Mobile phase              :Methanol: Acetonitrile   (50+50)
Column              :C18 250 x 4.6mm
Flow rate              :1.0ml/min
Runtime              :10min
PH                                      : 4.8       by H3PO4
Wave length              :262nm
Sample size  : 20 µl
Needle wash  : water HPLC grade 
Column temperature  : ambient
Fig 3: trail 1
Observation: There was no proper separation and merging of peaks was appeared.
Trial 2:
Chromatographic conditions:
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 Mobile phase  :Methanol: Water   (90+10)
 Column :C18 250 x 4.6mm
 Flow rate :1.0ml/min
 Runtime :10min
 PH  :5.2        by H3PO4    
Wave length              :262nm
Sample size  : 20 µl
Needle wash  : water HPLC grade 
Column temperature  : Ambient
Fig 4: trail 2
Observation: merging and no symmetry of peaks.
Trial 3:
Chromatographic conditions:
Mobile phase : Methanol: KH2Po4 (0.01M)  (50+50)
Column : C18 250 x 4.6mm
Flow rate : 1.0ml/min
Runtime : 7min
PH : 5.6     by H3PO4  
Wave length : 262nm
Sample size : 20 µl
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Needle wash : water HPLC grade 
 Column temperature : ambient
Fig 5: trail 3
          Observation: merging of peaks and no proper peak
Trial 4:
Chromatographic conditions:
Mobile phase             :Methanol: KH2Po4 (0.01M): Acetonitrile (50+25+25)
Column :C18 250 x 4.6mm
Flow rate :1.0ml/min
Runtime :6 min
PH             :4.9       by H3PO4
Wave length             :260nm
Sample size : 20 µl
Needle wash : water HPLC grade 
Column temperature : ambient
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         Fig 6: trail 4
        Observation:  Symmetrical Peak was not observed.
OPTIMIZED METHOD
Fixed chromatographic condition:
Detection:               260 nm
Mobile phase:               Methanol: kH2PO4 (0.01M):THF: Acetonitrile   (55+10+5+30)
Stationary phase:   C18 250 x 4.6mm
Flow rate:    1.2ml/min
Runtime:    10min
Retention time:    3.7 min
PH  :                                 5.5         by H3PO4   
Sample size:                   20 µl
Needle wash :                water HPLC grade
Column temperature:      room temperature (20ºC)
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       Fig 7: Fixed Chromatographic Condition
Observation:
Peak shape was good, theoretical plates were good and asymmetry was within the limit.
5.3 QUANTIFICATION STUDY
Preparation of Standard Solution:
1 gram of TENOFEVIR A.P.I. (pure drug form) was taken and dissolved in methanol
and  finally  made  the  volume  to  100ml  in  volumetric  flask  with  methanol.  Then  it  was
suitably diluted with methanol to produce final drug concentration of 100µg/ml. 
Preparation of Sample Solution:
The formulation tablets of Tenofevir (Tentide - 300 mg) were crushed to give finely
powdered material. Then tablet powder equivalent to 100 mg of tenofovir was transferred
into 100 ml flask and volume was made up with mobile phase and filtered through Ultipor
N66 Nylon 6, 6 membrane sample filter paper. Filtrate was suitably diluted with mobile phase
to produe drug concentration of 100µg/ml.
Recording of chromatogram:
With the optimized chromatographic conditions mentioned above, a steady baseline
for about 20 min was obtained. After the stabilization of the baseline for about 20 min, the
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standard and  sample solutions  were  injected  separately into  chromatographic system and
chromatogram was recorded until the reproducibility of the peak area was found satisfactory.
Retention time of  Tenofovir was found to be 3.7mins.
        Fig 8:Chromatogram of Blank
Fig 9:Chromatogram of standard
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           Fig 10:Chromatogram of sample
5.4 VALIDATION OF THE METHOD
After the development of HPLC method for the estimation of Tenofovir in a dosage
form, validation of the method was performed. This section described the procedure followed
for validation of the developed method.
1) Accuracy:
 Accuracy of  the method was determined  by standard addition method.  A known
amount  of  standard drug was added  to  the fixed amount  of  pre-analyzed  tablet  solution.
Percent recovery was calculated by comparing the area before and after the addition of the
standard drug. The standard addition method was performed at 50%, 100% and 150% level of
100ppm. The solutions were analyzed in triplicate at each level as per the proposed method.
The percent recovery and % RSD was calculated and results  are Satisfactory.  Recoveries
ranging from 99.0 to 100.1 were obtained by the proposed method. This indicates that the
proposed method was accurate.
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          Fig 11: Chromatogram of accuracy(a).
Fig 12: Chromatogram of accuracy(b).
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          Fig 13: Chromatogram of accuracy(c).
Table 2: Data of accuracy
Level
Amount of
Tenofevir spiked (µg)
Amount of
recovered(µg)
% Recovery %RSD
50 %
150 149 99.33
0.166150 149.5 99.66
150 149.2 99.46
100%
200 198.9 99.45
0.125200 199.2 99.6
200 199.4 99.7
150%
250 249.3 99.72
0.069250 249.3 99.72
250 249.0 99.6
Mean % of
recovery 99.58
Mean RSD
=0.12
Km college of pharmacy Page 41
Dept of Analysis
Acceptance Criteria:
For an assay method, mean recovery should be 100% ± 2% at each concentration over
the range of 50-150% of the target concentration.
2) Precision:
Repeatability and reproducibility studies were conducted to determine precision of the
method. Repeatability studies were done by consequently injecting the standard solution of
same concentration i.e.,100 µg/ml of Tenofovir. The solutions were prepared and injected as
per assay procedure.
Fig 14:Chromatogram of precision
Table 3: Data of repeatability
Km college of pharmacy Page 42
Dept of Analysis
Inj. No Peak Area
1. 24389
2. 24358
3. 24366
4. 24405
5. 24327
Avg                           24369
SD                           29.958
% RSD                           0.1229
Intraday Studies
Intraday studies were conducted to determine the solution stability. Intraday studies
were done by injecting the standard solution of Tenofovir at different intervals of time  and
the data was shown below:
Table 3(a):Intra day
Inj. No Conc.   of
Efavirenz
(µg/ml)
Time
Intervel(hrs)
Peak Area % RSD
1
2
3
    100
    100
    100
0
6
12
   24389
   24266
   24210
0.3770
Inter day Studies
Inter day studies were conducted to determine the solution stability in different days.
Inter day studies were done by injecting the standard solution of Tenofovir in different days
(Day1,Day2) and the data was shown below:
Table 3(b): Inter day Studies
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No of Injection Conc.   of
Tenofovir
(µg/ml)
Peak Area % RSD
Day 1 100 24389
24337
24256
0.286
Day 2 100 24227
24111
24132
0.255
Acceptance criteria
              The % Relative Standard Deviation of peak areas of  Tenofovir should not be more
than 2.0.
3) Linearity and Range:
From  the  standard  stock  solutions,  a  suitable  standard  solution  was  prepared  to
contain targeted level of the assay concentration of the standard drug. The solutions were
examined  by  the  assay  procedure.  The  standard  solution  of  Tenofovir  containing  100-
500µg/ml was injected and chromatogram was recorded and were appended in figure no 15-
20.   The calibration curve  was plotted  using peak area  Vs concentration of  the  standard
solution. From the calibration curve, the slope and intercept were calculated fig 20.
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Fig 15:Chromatogram of Tenofovir 50µg/ml
Fig 16:Chromatogram of Tenofovir 100µg/ml
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Fig 17:Chromatogram of Tenofovir 150µg/ml
Fig 18:Chromatogram of Tenofovir 200µg/ml
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Fig 19:Chromatogram of Tenofovir 250µg/ml
            Table 4:  Data of  linearity
                                         CONC                       AREA                 T.PLATES
50 µg 12246 10196
100 µg 24389 13211
150 µg 35038 10012
200 µg 46577 17945
250 µg 57734 15530
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Fig 20: caliberation curve
Acceptance Criteria
Coefficient of correlation should be not less than 0.999
 4) Limit of Detection (LOD) and Limit of Quantification (LOQ):
The  LOD  and  LOQ  of  the  developed  method  were  determined  by  analyzing
progressively low concentration of the standard solutions using the developed methods. The
LOD is the smallest concentration of the analyte that gives a measurable response . LOD of
Tenofovir was found to be 15 µg/ml. The LOQ is the smallest concentration of the analyte,
which gives response that can be accurately quantified (signal to noise ratio of 10). The LOQ
of Tenofovir was found to be 20 µg/ml.
5) Specificity
The specificity of the RP-HPLC method was determined by complete separation of
Tenofovir as shown in above Figures with parameters like retention time (tR), resolution (Rs)
and tailing factor (T), peak purity curve and peak purity index. Tailing factor for peaks of
Tenofovir was less than 2% and resolution was satisfactory. The average retention time ±
standard deviation for Tenofovir was found to be 4.1±0.0148 for six replicates. The peaks
obtained for Tenofovir was sharp and have clear baseline separation. The peak purity studies
were performed to prove that the method is specific in nature. 
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6) System Suitability Studies:
The system suitability studies were carried out as specified in USP. These parameters
include column efficiency, resolution and capacity factor.
Table 5: System Suitability Parameters
Validation Parameters Acceptance Criteria
Linearity range (µg/ml)
Correlation co-efficient (r2)
LOD (µg/ml)
LOQ (µg/ml)
Intraday (%RSD)*
Interday (%RSD)*
Repeatability (%RSD)*
Accuracy (%)
Peak purity index
Resolution factor (Rs)
       No. of theoretical plates (N)
               Tailing factor
50 - 250
0.999
15
20
0.377
0.281
0.1229
99.32 - 99.72
1.0000
-
                        24389
                          1.14               
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7) Robustness:
            In order to demonstrate the robustness of the method, the following optimized
conditions were slightly varied.
           1)  ± 2% in ratio of Methanol in mobile phase,
           2)  ± 0.1 ml of flow rate,
           3) ±  0.2 units in the pH.
            The separation factor, retention times and peak symmetry were then calculated.The
deviation among the results obtained is well within the limits. Hence the method is robusted.
Table 6: Robustness Studies
Chromatographic
Condition
Retention time % Accuracy
Actual concentration 3.747 99.72
Wavelength 261 3.932 99.66
Methanol ratio 40% 2.761 99.45
Flow rate 1.2 ml/min 3.215 99.33
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6. RESULTS AND DISCUSSION
The RP-HPLC method was developed for estimation of Efavirenz in tablet dosage
form and validation was performed in  accordance with ICH guidelines for  the  following
parameters  such as system suitability,linearity and range,  precision, accuracy,  ruggedness,
specificity  and  robustness.  The  summary  of  results  obtained  in  analytical  method
development and validation were shown in table 9.
Table 9: Data and Results
Parameters Acceptance Results
System suitability 1. % RSD NMT 2%
2. Tailing factor
NMT 2
3. Theoretical plates
NLT 2000
0.12 %
               
                  1.12
               
                passes
Specificity No interference with
blank
No Interference
Precision (Repeatability) % RSD NMT 2% 0.1229
Accuracy 98-103% 99.58
Linearity Correlation co-efficient
NLT 0.999
0.9994
Robustness System suitability
parameters should be
with in limit NMT 2%
   
                 Passes
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Validation summary report:
The observations and results obtained for each of the parameters like system 
suitability, linearity and range, precision (repeatability), intermediate precision, specificity, 
ruggedness and robustness lies well within the acceptance criteria. So the given method was 
simple, specific, linear, precise, accurate, robust and rugged and extensively used for the 
estimation tenofovir in tablet dosage form.
Discussion: 
The Reverse Phase High Performance Liquid Chromatography method was developed
a stability indicating assay method. Pure drug chromatogram was run in different  mobile
phases  containing  methanol,  water,  acetonitrile,  tetrahydrofuron  and  also  by  using
orthophosphoric acid. Different columns like C8  & C18   were used. The retention time and
tailing  factor  were  calculated.  Finally  the  mobile  phase  with  Methanol:  kH2PO4
(0.01M):THF: Acetonitrile    in the ratio of 55:10:5:30 whose PH is  adjusted to 5.5 using
orthophosphoric acid. Kromosil C18 250 x 4.6mm analytical column was selected which gives
a sharp peak and a symmetrical peak with 1.14 tailing. Calibration curve was found to be
linear at range 50µg/ml to 250 µg/ml. Five different concentrations of Tenofovir in range
above were prepared and 20µl of each concentration injected in HPLC. The slope(m) and
intercept  (c)  obtained  were  found  to  be  222.89  and  594.1.The  correlation  of  coefficient
(r2)obtained was found to be 0.9995.It was observed that the concentration range showed a
good relationship. The limit of detection for Tenofovir was found to be 0.43µg/ml and the
limit of quantification was found to be 1.33µg/ml. It proved the sensitivity of the method. The
percentage assay or average amount of Tenofovir in formulation was found to be 79.8%.The
low values of standard deviation and coefficient of variation at each level of the recovery
experiment indicate high precision of the method.
7. CONCLUSION
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From the experimental data results and parameters it was concluded that   the developed RP-
HPLC method has the following advantages:
 The standard and sample preparation requires less time
 No tedious extraction procedure was involved in the analytical process.
 Suitable for the analysis of raw materials.
 Run time required for recording chromatograms were less than 10 minutes 
 Hence, the chromatographic method developed for Tenofovir was found to be simple,
precise,  accurate and cost  effective and it  could be effectively applied for  routine
analysis in research institutions,  quality control  department in industries,  approved
testing  laboratories,  bio-pharmaceutics  and  bio-equivalence  studies  and  in  clinical
pharmacokinetic studies in near future.
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